advertisement
11.8 Neuroprotection (8)
Showing records 1 to 8
Display all abstracts in classification 11.8 Neuroprotection
Search within classification 11.8 Neuroprotection5684 Potential role for Ginkgo biloba extract in the treatment of glaucoma
Ritch R
Medical Hypotheses 2000; 54: 221-235
5830 Tenascin-R inhibits regrowth of optic fibers in vitro and persists in the optic nerve of mice after injury
Becker T; Anliker B; Becker CG; Taylor J; Schachner M; Meyer RL; Bartsch U
GLIA 2000; 29: 330-346
5831 The effects of FK506 on retinal ganglion cells after optic nerve crush
Freeman EE; Grosskreutz CL
Investigative Ophthalmology and Visual Science 2000; 41: 1111-1115
5832 Neuroprotective effect of N-methyl-D-aspartate receptor antagonists in an experimental glaucoma model in the rat
Gu Z; Yamamoto T; Kawase C; Matsubara M; Kawase K; Sawada A; Kitazawa Y
Nippon Ganka Gakkai Zasshi 2000; 104: 11-16
5833 Attenuation of ganglion cell dysfunction: a goal for glaucoma treatment in the new millennium
Osborne NN; DeSantis L; Melena J; Chidlow G; Wood JPM
Ophthalmology Clinics of North America 2000; 13:123-130
5834 Neuroprotection: is it already applicable to glaucoma therapy?
Ritch R
Current Opinions in Ophthalmology 2000; 11: 78-84
5835 Neuroprotection: a new treatment modality for glaucoma?
Schwartz M; Yoles E
Current Opinions in Ophthalmology 2000; 11: 107-111
5836 Lomerizine, a Ca2+ channel blocker, reduces glutamate-induced neurotoxicity and ischemia/reperfusion damage in rat retina
Toriu N; Akaike A; Yasuyoshi H; Zhang S; Kashii S; Honda Y; Shimazawa M; Hara H
Experimental Eye Research 2000; 70: 475-484
